ROTHBLATT MARTINE A sold UTHR
November 14, 2025 · Form 4 insider transaction
ROTHBLATT MARTINE A sold 930 shares of United Therapeutics Corporation at $464.84 per share, a transaction worth $432.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on May 2, 2025. This plan will continue until the earlier of: (a) exhaustion of a tranche of 294,000 stock options that expire March 15, 2026; or (b) December 31, 2025.; This transaction was executed in multiple trades at prices ranging from $464.40 to $465.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.